Compare DexCom, Inc. (DXCM) vs Marathon Petroleum Corp (MPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Marathon Petroleum Corp — how do they compare? DexCom, Inc. trades at $77.85 (market cap $28.06B), while Marathon Petroleum Corp trades at $307.85 (market cap $87.34B). The key difference: Marathon Petroleum Corp is far larger — about 3.1× DexCom, Inc.'s market cap, and Marathon Petroleum Corp pays a 1.31% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | MPC | |
|---|---|---|
Market Cap | $28.06B | $87.34B |
Sector | Health | Energy |
52-Week High | $89.53 | $303.40 |
52-Week Low | $54.84 | $158.59 |
Enterprise Value | $27.03B | $119.52B |
Dividend Yield | — | 1.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Marathon Petroleum (MPC) trades at $308.19, up 1.58% today, with strong technical momentum and bullish moving averages. The stock shows robust profitability with a 27.92% ROE and 3.42% net margin, though revenue has declined from $177.5B in 2022 to $132.7B in 2025. Recent news highlights refining margin strength driving outperformance, with 75.76% analyst buy ratings supporting positive sentiment.
Outlook remains favorable due to elevated refining margins and strategic upgrades, but risks include revenue declines, legal challenges from AI pricing lawsuits, and geopolitical tensions affecting oil markets. The consensus price target of $292.70 suggests modest downside from current levels despite overall bullish analyst coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →
